Get notified when ACH files again. Create a free account and we'll email you the moment its next filing is analyzed.
Get filing alertsRed Flags Detected
- Debt Refinancing At Substantially Higher Rates (9.000%-9.750% Vs. 4.500%-6.625%) (new) — The company is refinancing existing debt at roughly double the interest rate, indicating deteriorated creditworthiness and significantly higher future interest expense.
- Exchange Offers Include Consent To Eliminate Substantially All Covenants And Certain Events Of Default (new) — The company is seeking to strip creditor protections from existing note indentures, reducing bondholder safeguards against future deterioration.
- Filing Warns Failure To Complete Transactions Could Materially Adversely Affect Financial Condition (new) — The company explicitly states it is in a precarious financial position requiring debt restructuring to avoid distress, indicating execution risk is material.
- Loss Of Large Commercial Payor Contract Representing $335-345m Revenue (12-13% Of Total) (new) — The company lost a major customer generating material revenue and EBITDA, requiring significant operational restructuring and contributing to near-term revenue decline.
Accendra Health secures $326M debt refinancing to extend maturities amid contract loss
Filed May 11, 2026 · Period ending May 11, 2026 · ~2 min read
Key Changes
-
high
Company entered commitment letter for $326.25M new 9.000% first-lien notes due 2032 and exchange of existing 4.500%/6.625% notes into 9.000%/9.750% secured notes, with creditor support from 100% of 2029 noteholders and 83% of 2030 noteholders.
Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR → -
high
Refinancing extends weighted average debt maturity from 2.7 years to 5.5 years and reduces funded debt by $116M through exchange, addressing near-term maturities but at substantially higher interest rates (9.000%-9.750% vs. 4.500%-6.625%).
Exhibit 99.1 view on EDGAR → -
high
Company lost large commercial payor contract generating $335-345M annual revenue and $35-45M EBITDA; implementing capacity adjustment and cost realignment plan including footprint reduction and organizational redesign.
Exhibit 99.1 view on EDGAR →
2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.
Want to see a complete report first? Today's free report (FNGR 10-Q) is open in full — no account needed.
Partner
Trade ACH commission-free
Open an account, get a free stock.
Investing involves risk. Free stock terms apply.
Thanks — your feedback helps us improve report quality.
Source-verified from EDGAR · Narrative written by AI · Jun 21, 2026 · How we verify